Malignant tumors of the salivary glands are rare, accounting for approximately 1–7% of all head and neck tumors. The parotid gland is the most commonly affected gland. An accurate preoperative diagnosis distinguishing between malignant and benign tumors is necessary for the appropriate management of patients. The aim of this review is to analyze the results of the most recent literature studying the use of radiomics in malignant tumors of the parotid gland. A comprehensive literature review was performed using the PubMed/MEDLINE, EMBASE and Cochrane Library databases, in accordance with the PRISMA review criteria (from 2020 to July 2025). The final analysis comprised a total of six articles and 560 patients. Four studies evaluated the role of Magnetic Resonance Imaging (MRI), one of Computed Tomography (CT) and one of Positron Emission Tomography/Computed Tomography (PET/CT). Radiomics models achieved good overall diagnostic performance, with AUC values ranging from 0.769 to 0.952 across studies, although methodological heterogeneity prevented data pooling. The results of this review indicate that radiomics has the potential to play an important role in the management of malignant tumors of the parotid gland. Nevertheless, the absence of clear and standardized protocols does not allow the comparison of results. Further studies are necessary to confirm these findings.
涎腺恶性肿瘤较为罕见，约占所有头颈部肿瘤的1%-7%，其中腮腺是最常受累的腺体。为制定合适的治疗方案，术前准确鉴别肿瘤良恶性至关重要。本文旨在系统分析近期关于影像组学在腮腺恶性肿瘤中应用的最新文献成果。依据PRISMA综述标准（检索时限为2020年至2025年7月），我们在PubMed/MEDLINE、EMBASE和Cochrane Library数据库进行了全面文献检索。最终共纳入6篇文献，涉及560例患者。其中4项研究评估了磁共振成像（MRI）的应用价值，1项研究聚焦计算机断层扫描（CT），另1项研究探讨正电子发射断层扫描/计算机断层扫描（PET/CT）的作用。尽管研究方法存在异质性导致数据无法合并分析，但影像组学模型整体展现出良好的诊断效能，各研究受试者工作特征曲线下面积（AUC）值介于0.769至0.952之间。本综述结果表明，影像组学在腮腺恶性肿瘤的诊疗管理中具有重要应用潜力。然而，由于缺乏明确统一的标准化方案，目前研究结果尚难以直接比较。未来仍需进一步研究验证这些发现。
Role of Radiomics in Parotid Malignant Disease: A Scoping Review
肿瘤(癌症)患者之家